Impingement syndrome of shoulder. Impingement syndrome of shoulder
Conditions
Interventions
Intervention 1: In Group A subacromial ketorolac injection with a posterior approach will be done. Intervention 2: In Group B subacromial Triamcinolon injection with a posterior approach will be done.
Treatment - Drugs
In Group A subacromial ketorolac injection with a posterior approach will be done.
In Group B subacromial Triamcinolon injection with a posterior approach will be done.
In Group C subacromial Betamethazon LA injection with a posterior approach will be done.
Sponsors
Vice Chancellor of Reaserch and Technology, Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: all people with shoulder pain referred to orthopedic clinics and diagnostic imaging in the diagnosis of shoulder impingement syndrome has been laid for them and their consent to participate in the study. Exclusion criteria: patients with all of the diagnosis except impingement syndrome; Do not go to the next follow up; do not have a history of shoulder dislocation or fracture or a systemic disease that affects the joint and soft tissue .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determine the function of the patient. Timepoint: Before injection, weeks 2, 4 and 6 after injection. Method of measurement: By Oxford Shoulder Score questionnaire.;Patient pain severity. Timepoint: Before injection, weeks 2, 4 and 6 after injection. Method of measurement: By Visual Analogus Scale questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Tendon Rupture. Timepoint: weeks 2, 4 and 6 after injection. Method of measurement: Physical Examination.;Injection site infection. Timepoint: weeks 2, 4 and 6 after injection. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Hamed Abolhassani
Babol University of Medical Sciences
Outcome results
None listed